OPKO Health Files 8-K for 'Other Events' and Exhibits
Ticker: OPK · Form: 8-K · Filed: Jan 5, 2024 · CIK: 944809
| Field | Detail |
|---|---|
| Company | Opko Health, INC. (OPK) |
| Form Type | 8-K |
| Filed Date | Jan 5, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.01, $200.0 |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: 8-K, corporate-filing, other-events
TL;DR
**OPK filed an 8-K for 'Other Events' and exhibits, signaling upcoming news.**
AI Summary
OPKO Health, Inc. filed an 8-K on January 4, 2024, to report 'Other Events' and 'Financial Statements and Exhibits.' This filing, under the ticker OPK on the NASDAQ Global Select Market, indicates that the company is providing updated information, though the specific details of these events are not disclosed in the summary. For investors, this matters because an 8-K filing often precedes significant news, and while the content isn't detailed here, it signals that OPKO is communicating new developments that could impact its stock price.
Why It Matters
This 8-K signals that OPKO Health is disclosing new information, which could be anything from a new contract to a change in management, potentially impacting investor sentiment and stock valuation.
Risk Assessment
Risk Level: medium — The filing is vague, indicating 'Other Events' without specifics, which creates uncertainty about the nature and impact of the disclosed information.
Analyst Insight
A smart investor would monitor OPKO Health's news releases and subsequent SEC filings closely for the specific details of the 'Other Events' and 'Financial Statements and Exhibits' mentioned, as these could significantly impact the company's outlook and stock performance.
Key Numbers
- $0.01 — par value per share (the par value of OPKO Health's Common Stock)
- 20240104 — Conformed Period of Report (the date the reported event occurred)
- 15 — Public Document Count (the number of documents included in the filing)
Key Players & Entities
- OPKO Health, Inc. (company) — the registrant filing the 8-K
- NASDAQ Global Select Market (company) — the exchange where OPKO's common stock is registered
- January 4, 2024 (date) — the date of the earliest event reported in the 8-K
- 001-33528 (dollar_amount) — OPKO's Commission File Number
- OPK (company) — OPKO Health's trading symbol
Forward-Looking Statements
- OPKO Health will release more detailed information regarding the 'Other Events' mentioned in this 8-K within the next few weeks. (OPKO Health, Inc.) — medium confidence, target: 2024-02-01
FAQ
What specific items are being reported under 'Other Events' in this 8-K filing by OPKO Health, Inc.?
The filing indicates 'ITEM INFORMATION: Other Events' but does not provide specific details about what those events are within the provided text. It only states that such events are being reported.
What is the trading symbol and the exchange where OPKO Health, Inc.'s common stock is registered?
OPKO Health, Inc.'s common stock trades under the symbol OPK and is registered on the NASDAQ Global Select Market, as stated in the 'Securities registered pursuant to Section 12(b) of the Act' section.
What is the earliest event reported date for this 8-K filing?
The earliest event reported date for this 8-K filing is January 4, 2024, as indicated by 'Date of Report (Date of earliest event reported): January 4, 2024'.
What is the business address and phone number of OPKO Health, Inc.?
OPKO Health, Inc.'s business address is 4400 Biscayne Blvd., Miami, Florida 33137, and its telephone number is (305) 575-4100, according to the filing's business address section.
Under which sections of the Securities Exchange Act of 1934 is this current report being filed?
This current report is being filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, as stated in the 'FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934' section.
Filing Stats: 557 words · 2 min read · ~2 pages · Grade level 11.4 · Accepted 2024-01-05 07:00:30
Key Financial Figures
- $0.01 — ch registered Common Stock , par value $0.01 per share OPK NASDAQ Global Select M
- $200.0 — reviously announced private offering of $200.0 million aggregate principal amount
Filing Documents
- opk20240104_8k.htm (8-K) — 26KB
- ex_612114.htm (EX-99.1) — 16KB
- ex_612114img001.jpg (GRAPHIC) — 4KB
- 0001437749-24-000675.txt ( ) — 182KB
- opk-20240104.xsd (EX-101.SCH) — 3KB
- opk-20240104_def.xml (EX-101.DEF) — 11KB
- opk-20240104_lab.xml (EX-101.LAB) — 15KB
- opk-20240104_pre.xml (EX-101.PRE) — 11KB
- opk20240104_8k_htm.xml (XML) — 2KB
01
ITEM 8.01. Other Events.   On January 4, 2024, OPKO Health, Inc., a Delaware corporation (the "Company"), issued a press release in accordance with Rule 135c promulgated under the Securities Act of 1933, as amended (the "Securities Act"), with respect to the pricing of its previously announced private offering of $200.0 million aggregate principal amount of its 3.75% Convertible Senior Notes due 2029 to persons reasonably believed to be qualified institutional buyers in accordance with Rule 144A under the Securities Act.  In accordance with Rule 135c(d), a copy of such press release is filed as Exhibit 99.1 to this Current Report on Form 8-K and incorporated by reference in this Item 8.01.  
Financial Statements and Exhibits
Financial Statements and Exhibits.     (d) Exhibits   Exhibit  No.   Description     99.1   Rule 135c Press Release of the Company, dated January 4, 2024 104   Cover Page Interactive Data File (embedded within the Inline XBRL document)        
SIGNATURES
SIGNATURES   Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.       OPKO Health, Inc.             By: /s/ Steven D. Rubin Date: January 5, 2024   Name: Steven D. Rubin     Title: Executive Vice President-Administration